{"pub": "marketwatch", "url": "https://marketwatch.com/story/nektar-worst-performing-stock-in-sp-500-booted-from-index-2019-09-26", "downloaded_at": "2019-09-26 23:46:24.940244+00:00", "title": "Nektar, worst performing stock in S&P 500, booted from index", "language": "en", "text": "S&P Dow Jones Indices announced late Thursday it was booting Nektar Therapeutics NKTR, -6.60% from the S&P 500 index SPX, -0.24%. Nektar was the worst performing stock on the benchmark index in the past 12 months, dropping more than 70%. Nektar's earnings per share fell 112% in the second quarter, the third worst performance among companies included in the S&P 500. Nektar is set to be replaced by Las Vegas Sands Corp. LVS, -2.10%, which gained more than 5% in the extended session Thursday. The change will take effect Oct. 3. Nektar stock was up 1.9% in after-hours trading Thursday and will move to the S&P MidCap 400. This is the third announced change to the S&P 500 in the past two weeks. Previously, S&P Dow Jones Indices announced that NVR Inc. NVR, +1.03% and CDW Corp. CDW, +1.55% would join the benchmark S&P 500.", "description": "S&P Dow Jones Indices announced late Thursday it was booting Nektar Therapeutics from the S&P 500 index . Nektar was the worst performing stock on...", "authors": ["Max A. Cherney"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-09-26"}